Global laboratory animal models, 3D cultures and organoids

Dublin, Sept. 21, 2022 (GLOBE NEWSWIRE) — The “Laboratory animal models, 3D cultures and organoids: global markets” report has been added to from ResearchAndMarkets.com offer.

The report describes three global markets: the animal model market, the 3D culture market and the organoid market. The organoids market in particular is described in more detail, with market estimation for different segments in a separate chapter of the report.

The rapid growth rate of the renal segment is attributed to the increasing adoption of renal organoids, which results from their exceptional ability, derived from the use of disease-specific human pluripotent stem cells (hPSCs), to reproduce human diseases caused by genetic alterations. This helped usher in the next generation of kidney disease models.

Descriptive company profiles of major organoid market players including Cellesce Ltd., Corning Inc., Merck KGaA, Thermo Fisher Scientific Inc., Hubrecht Organoid Technology (HUB) and STEMCELL Technologies Inc.

The report includes

  • 26 data tables and 28 additional tables
  • An up-to-date review and analysis of the global markets for laboratory animal models, 3D cell cultures and organoids within the industry
  • Global market trend analyses, with historical market revenue data for 2019-2021, estimates for 2022, and compound annual growth rate (CAGR) projections to 2027
  • Highlights of the current state of the industry structure, new technological updates and issues related to organoid integration and stringent regulatory constraints, ongoing research activities and the impact of COVID -19 in the whole market
  • Estimation of the real market size and market forecast for Organoids in millions of dollars, and analysis of their corresponding market share by product type, application and geographical region
  • Region and country specific data and analysis for Organoids in United States, Canada, Germany, United Kingdom, France, Italy, Spain, Japan, Australia, China and India etc. .
  • Information on current trends that significantly affect basic research, biomedical and other industries where animals are used for toxicity testing and also to assess the safety and metabolism of chemical compounds
  • Analysis of market opportunities with a holistic review of the pros and cons of 3D cell cultures, animal models, and organoids in the mainstream biopharmaceutical industry
  • Review of Selected Organoid Patents and Patent Applications and Emerging Developments in the Global Market
  • Identification of key stakeholders and analysis of the competitive landscape based on recent developments and industry revenue

Main topics covered:

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Chapter 3 Technological Background of Animal Models Market

  • Methods for modifying animal model and 3D cell culture
  • Physical and chemical mutations
  • Target mutations
  • Other technologies
  • Laboratory animal models
  • Market definition
  • Lines of animal models
  • Common species of laboratory animals

Chapter 4 Impact of Covid-19 on Global Organoids Market

  • Insight
  • Impact of Covid-19 on organoids
  • Conclusion

Chapter 5 Market Dynamics

  • Market factors
  • Put more emphasis on the development of alternative approaches to animal testing
  • Growing Demand for Tumor Modeling and Biobanking to Drive Market Growth
  • Increased adoption of organoid technology for a wide range of applications
  • Market constraints
  • Rigorous government regulatory framework in the research and development of cell cultures and stem cells
  • Concerns Associated with Integrating Organoids into Current Workflows
  • Market opportunities
  • Increasing applications of organoids in drug development, personalized medicine, and transplantation medicine

Chapter 6 Background of 3D Cell Technology

  • 3D cell cultures
  • Spheroids
  • 2D cultures vs. 2.5D cultures vs. 3D crops
  • Scaffold-based and scaffold-free 3D cell cultures
  • 3D cell cultures without scaffolding
  • Scaffold-based 3D cell cultures
  • Tissue engineering and bioprinting
  • 3D bioprinting technology
  • Types of bioprinting methods
  • Organ-on-a-chip microfluidic platforms
  • Types of organ-on-chip devices

Chapter 7 Market Breakdown by Organ Type

  • Global Organoid Market, By Organ Type
  • Intestine
  • Market size and forecast
  • Liver
  • Stomach
  • Pancreas
  • Lung (Pulmonary)
  • Kidney
  • Others
  • Cardiac organoids
  • cancer organoids

Chapter 8 Market Split by Application

  • Global Organoids Market, By Application
  • Developmental biology
  • Market size and forecast
  • Drug discovery and personalized medicine
  • Regenerative medicine
  • Pathology of infectious diseases
  • Drug toxicity and efficacy testing

Chapter 9 Market Breakdown by Region

  • Global Organoids Market, By Region
  • North America
  • WE
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • The rest of Europe
  • Asia Pacific
  • China
  • Japan
  • Australia
  • India
  • Rest of Asia-Pacific
  • Rest of the world
  • Market size and forecast

Chapter 10 Patent Examination/New Developments

Chapter 11 Market Opportunity Analysis

  • Market Opportunities: Animal Models
  • Market Opportunities: 3D Cell Culture Segment
  • Organs on a chip
  • Organoids
  • Bioprinting
  • Advantages and disadvantages of 3D cell cultures and animal models
  • animal models
  • 3D cell cultures in general
  • Organoids
  • Organs on a chip

Chapter 12 Competitive Landscape

Chapter 13 Profiles of Significant Companies and Institutions

  • Animal Model Companies
  • Alpha Genesis Inc.
  • Charles River International Laboratories Inc.
  • Envigo
  • Genoway SA
  • Drug Development Labcorp (Covance Inc.)
  • The Jackson Lab
  • January Labs
  • Genetics Oak Hill
  • Primegen
  • Taconic Biosciences
  • Transgenic Inc.
  • Transposagen Biopharmaceuticals Inc.
  • Bio-printing and regenerative medicine companies
  • Allevi
  • Aspect Biosystems Ltd.
  • Bioink Solutions Inc.
  • Celllink Inc.
  • Collplant Holdings Ltd.
  • East River Biosolutions/Xylyx Bio
  • Epibone
  • Mattek Corp.
  • Nano 3D Biosciences Inc.
  • Organovo Holdings Inc.
  • Pepgel LLC
  • Regenhu
  • Tevido Biodevices Inc.
  • Fabrics GmbH
  • Organ-on-a-chip companies
  • Axosim
  • Emulate Inc.
  • Kirkstall Ltd.
  • Micronit Microtechnologies
  • mimetas
  • Tara Biosystems Inc.
  • Organoid companies
  • 3Dnamics Inc.
  • Cellesce
  • Cincinnati Children’s Hospital Medical Center
  • Crown Bioscience
  • Corning inc.
  • Define
  • Hubrecht Organoid Technology (Hub)
  • Merck Kgaa
  • R&D Systems Inc.
  • Stemcell Technologies Inc.
  • Thermo Fisher Scientific
  • Trevigen inc. (Bio-Techne)
  • Other 3D cell culture companies
  • 3D Biotek LLC
  • Advanced Biomatrix Inc.
  • Horizon Discovery Ltd.
  • Insphero Inc.
  • Promocell GmbH
  • Reprocell Inc.
  • Synthecon Inc.

For more information on this report, visit https://www.researchandmarkets.com/r/lzsaf


Comments are closed.